Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs at Johnson & Johnson (JNJ), executed a significant sale of company shares on July 20, 2026. Broadhurst sold 23,054 shares at an average price of $251.27 each, resulting in a transaction valued at approximately $5.79 million.
This transaction follows another notable insider sale by Kathryn E. Wengel, who sold 10,000 JNJ shares for roughly $2.41 million on June 11, 2026. Insider stock sales can occur for a variety of reasons, including personal financial planning, tax considerations, or diversification strategies, and do not inherently signal a negative view of the company's prospects.